Project Grant R01AR083375

Award Date 8/30/24
Completion Date 7/31/29
Dollars Obligated $489K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Lexington, KY 40526, USA
Similar Awards
This $139,050 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support a research project led by Dr. Stephan Bodkin at the University of Utah. The project aims to investigate skeletal muscle remodeling and the infiltration of intramuscular adipose tissue following traumatic knee injuries, such as anterior cruciate ligament (ACL) reconstruction....
The National Institute on Aging (NIA) awarded a $1,023,154 Project Grant under the Aging Research program (CFDA 93.866) to the University of Colorado-Denver to evaluate the effectiveness and implementation of neuromuscular electrical stimulation (NMES) in rehabilitation after total knee arthroplasty (TKA). The project aims to conduct a cluster randomized trial across 30 outpatient physical therapy clinics in two healthcare systems (Intermountain Health and UCHealth) to compare outcomes between...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $549,437 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to The Trustees of the University of Pennsylvania. The grant, effective September 1, 2024 through June 30, 2029, aims to locally deliver a small molecule Hedgehog signaling agonist to increase the formation of zonal tendon-to-bone attachments and improve outcomes following anterior cruciate...
This $147,236 Project Grant was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant funds a multifaceted study to quantify the mechanical effects of knee bracing and predict their ability to prevent ligamentous injury, with a focus on the medial collateral ligament (MCL), which is the most commonly injured structure in the knee. The research utilizes a 6 DOF...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) provides $400,526 to Rhode Island Hospital to investigate neuromuscular response differences between two anterior cruciate ligament (ACL) surgery procedures. The research aims to: Use machine learning to classify neuromuscular activity patterns in patients who received the novel...
This Project Grant award, funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA Program 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, aims to examine the efficacy of a rehabilitation approach called Rehabilitation with Exercise and Psychological Support (REPS) for patients who have undergone Anterior Cruciate Ligament (ACL) reconstruction. The $556,160 award, with a project period from September 2024 to August 2027, will...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $468,769 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to The Washington University to conduct preclinical research evaluating physical and biological interventions to reduce post-traumatic joint contracture (PTJC). The 5-year project aims to identify key parameters of physical therapy protocols and anti-inflammatory/immune system modulation strategies that can best...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) has awarded Collamedix Inc. a $300,000 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to establish the feasibility of their "CollaLink" collagen-based scaffold for augmenting primary repair of anterior cruciate ligament (ACL) mid-substance tears. The project aims to demonstrate that the CollaLink scaffold, when placed around an ACL tear, can provide a...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $678,213 project grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The project, titled "Evaluating Over Constraint of the Patella Following MPFL Reconstruction as a Contributing Factor to Progressive Cartilage Degradation", will characterize the progression of cartilage degradation in...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $469,766 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to the University of Wisconsin - Madison. The objective of this 4-year project, with a start date of February 27, 2025, is to obtain a cellular-level understanding of how nanogenerator-driven electrical stimulation (NG-ES) achieves accelerated wound healing in multiple clinically-relevant models...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $488,782 Project Grant (CFDA 93.846) to The University of Kentucky Research Foundation to conduct research on the use of neuromuscular electrical stimulation (NMES) to address quadriceps weakness and atrophy following anterior cruciate ligament (ACL) injury and reconstruction. The research aims to establish the mechanistic basis for how NMES can mitigate denervation-induced signaling within the quadriceps muscle, providing critical insight to overcome barriers in the development of evidence-based rehabilitation protocols for ACL injuries. The project will utilize innovative pre-clinical experiments and a targeted clinical trial to investigate the signaling cascades precipitating quadriceps neuromuscular dysfunction after ACL injury and the therapeutic potential of NMES. The results are expected to directly inform new treatments to advance the care of individuals with ACL injuries and address the persistent issue of quadriceps weakness.

Generated 6/10/25, 3:58 AM